A blood-based next-generation sequencing assay that detects DNA and RNA biomarkers for cancer profiling to guide diagnosis and treatment.

A proprietary sequencing technology that uses molecular barcodes and error correction to improve sensitivity in detecting multiple mutation types in liquid biopsy tests.